CLINICAL LABS & IMMUNODIAGNOSTICS

Shaping the future of diabetes, together

We are shaping the future of diabetes care with innovative technology to empower clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages.
We are shaping the future of diabetes care with innovative technology to empower clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages.

Boost your lab’s productivity and efficiency with our VITROS® Diabetes Menu

fh-icons
Excellent accuracy

Traceable to standardized materials and good correlation with other commercial assays

fh-icons
Long on-analyzer stability

Optimizes reagent use and decreases waste

fh-icons
Long calibration stability

Decreases the number of calibration events

fh-icons
Single-use tips and tests

No cuvettes to wash, no probes to clean, no risk of sample nor reagent carry-over

fh-icons
Highly specific detection

Highly specific antibodies and chemistry detection methods

fh-icons
Minimal interferences

None-to-minimal cross-reactivity and minimal interferences

Innovative MicroSlide design

Our VITROS® MicroSlide Technology uses a dry multi-layer, integrated testing environment to optimize each processing step for excellent accuracy and precision.

  • Excellent performance stability
  • Application of sample activates the dry slide reagent
  • Unique spread layer traps endogenous interferents (HIT, drugs, paraproteins, etc.)
  • Small sample sizes ideal for precious, hard-to-draw patients (2.7 -11.0 µL)

Insulin

VITROS® Immunodiagnostic Products Insulin Reagent

The VITROS Insulin assay has excellent performance to help clinicians understand the cause of a patient’s hypoglycemia or differentiate between type I and type II diabetes. Measuring insulin levels can evaluate the production and resistance.

The VITROS Insulin assay antibody is highly specific for insulin detection, with no cross-reactivity to C-peptide or Proinsulin.* Importantly it has insignificant or no cross-reactivity to insulin analogs commonly used in diabetes treatment.
*Ding, Qian. Performance Comparison of VITROS Immunodiagnostic Products Insulin Assay. Ortho Clinical Diagnostics PR-03149. 2017

C-Peptide

VITROS® Immunodiagnostics C-Peptide Assay

C-peptide testing provides a reliable assessment of beta-cell function and aids in differentiating Type I, Type II diabetes and MODY. Differentiating the diabetes type at clinical presentation is challenging and treatment decisions can improve with clear answers.

The VITROS C-Peptide assay uses an antibody highly specific for C-Peptide detection with no significant cross-reactivities to insulin, proinsulin, glucagon, calcitonin or somatostatin.

β-Hydroxybutyrate LiquiColor® Assay*

When seconds count in the ED, confidence is everything

Diabetic Ketoacidosis (DKA) can manifest as the first sign of diabetes for patients with type 1 and can occur in severe cases of hyperglycemia for patients with type 2 diabetes.

The ß-Hydroxybutyrate LiquiColor Assay* quantitatively measures ß-Hydroxybutyrate (BHB), the major ketone by product from the body metabolizing stored fat in the liver when glucose is not available. The buildup of ketones in the blood can be fatal if left unchecked.

The ß-Hydroxybutyrate LiquiColor Assay* is highly specific and is not susceptible to interferences for excellent performance on VITROS Systems. This lifesaving test is ready when you are.

*MicroTip Partnership Assay. May not be available in all countries.

VIPLabTech

Service & Support

Imagine going from clutter to clarity and having seamless control of your lab. Our Ortho Care® Services and Informatics gives you the freedom to focus on patient care.

VIPLabTech

Informatics Solutions

Is it time to change the way you see your lab? Simplify data to unburden you from the disruptions, complexities and distractions that pull your focus away from patient care. See how network insights, open connectivity and quality management can drive the change your lab needs.